Contribution of activation of K+ channels to glyceryl trinitrate-induced relaxation of rabbit aorta

General Pharmacology
T IshibashiS Imai

Abstract

1. Possible contribution of K+ channel opening to the relaxation by glyceryl trinitrate (GTN) was examined using isolated rabbit aorta. 2. While glibenclamide and apamin failed to affect relaxation by GTN, both charybdotoxin (ChTx) and iberiotoxin (IbTx) effectively attenuated GTN-induced relaxation. 3. The increase in cGMP produced by GTN was not attenuated by ChTx and IbTx. 4. The inhibitory effect of ChTx on GTN-induced relaxation was not reduced in the presence of zaprinast, indicating that cGMP but not GMP was responsible for activation of the K+ channel. 5. Okadaic acid, a selective inhibitor of protein phosphatase 2A, had no effect on the relaxation by GTN. These results indicate that, though small in degree, activation of a ChTx-sensitive K+ channel (large conductance Ca(2+)-activated K+ channel) is involved in the GTN-induced relaxation in rabbit aorta.

References

Sep 4, 1992·European Journal of Pharmacology·M L CandenasJ D Martín
Jan 1, 1991·Pharmacology & Therapeutics·W J Thompson
Apr 1, 1991·British Journal of Pharmacology·K A GreenR C Small
Aug 1, 1991·Pflügers Archiv : European journal of physiology·H PavenstädtR Greger
Jul 1, 1987·The Journal of General Physiology·A Hermann, C Erxleben
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Gimenez-GallegoM L Garcia
Jun 1, 1989·The Journal of General Physiology·S B SandsM D Cahalan
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M PriceC Deutsch
Mar 31, 1989·Biochemical and Biophysical Research Communications·H IshiharaD Uemura
Jan 1, 1989·Annual Review of Physiology·R LatorreO Alvarez
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D L WilliamsJ P Reuben
Jan 1, 1980·British Journal of Pharmacology·T Karashima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.